REIT - Residential
Compare Stocks
4 / 10Stock Comparison
CLPR vs NHI vs OHI vs VRE
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Healthcare Facilities
REIT - Residential
CLPR vs NHI vs OHI vs VRE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | REIT - Residential | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Residential |
| Market Cap | $50M | $3.64B | $13.74B | $1.78B |
| Revenue (TTM) | $153M | $403M | $1.24B | $291M |
| Net Income (TTM) | $-20M | $148M | $632M | $70M |
| Gross Margin | 80.2% | 61.3% | 85.5% | 23.4% |
| Operating Margin | 2.7% | 48.5% | 64.3% | 14.7% |
| Forward P/E | — | 22.2x | 23.4x | 23.7x |
| Total Debt | $0.00 | $1.16B | $4.26B | $1.37B |
| Cash & Equiv. | $31M | $20M | $27M | $14M |
CLPR vs NHI vs OHI vs VRE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Clipper Realty Inc. (CLPR) | 100 | 42.3 | -57.7% |
| National Health Inv… (NHI) | 100 | 135.3 | +35.3% |
| Omega Healthcare In… (OHI) | 100 | 148.1 | +48.1% |
| Veris Residential, … (VRE) | 100 | 124.7 | +24.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CLPR vs NHI vs OHI vs VRE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CLPR is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 0 yrs, beta 0.95, yield 13.9%
- 13.9% yield, vs VRE's 1.7%
NHI is the clearest fit if your priority is value.
- Lower P/E (22.2x vs 23.7x)
OHI carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 14.0%, EPS growth 25.2%, 3Y rev CAGR 10.9%
- 110.0% 10Y total return vs NHI's 58.9%
- 14.0% FFO/revenue growth vs CLPR's 3.0%
- 51.0% margin vs CLPR's -13.0%
VRE is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 0.22, current ratio 0.08x
- Beta 0.22, yield 1.7%, current ratio 0.08x
- Beta 0.22 vs CLPR's 0.95
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 14.0% FFO/revenue growth vs CLPR's 3.0% | |
| Value | Lower P/E (22.2x vs 23.7x) | |
| Quality / Margins | 51.0% margin vs CLPR's -13.0% | |
| Stability / Safety | Beta 0.22 vs CLPR's 0.95 | |
| Dividends | 13.9% yield, vs VRE's 1.7% | |
| Momentum (1Y) | +36.9% vs CLPR's -14.2% | |
| Efficiency (ROA) | 6.1% ROA vs CLPR's -1.6%, ROIC 6.0% vs 0.6% |
CLPR vs NHI vs OHI vs VRE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CLPR vs NHI vs OHI vs VRE — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
OHI leads in 3 of 6 categories
CLPR leads 1 • NHI leads 0 • VRE leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
OHI leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
OHI is the larger business by revenue, generating $1.2B annually — 8.1x CLPR's $153M. OHI is the more profitable business, keeping 51.0% of every revenue dollar as net income compared to CLPR's -13.0%. On growth, NHI holds the edge at +29.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $153M | $403M | $1.2B | $291M |
| EBITDAEarnings before interest/tax | $36M | $282M | $1.1B | $129M |
| Net IncomeAfter-tax profit | -$20M | $148M | $632M | $70M |
| Free Cash FlowCash after capex | $7M | $226M | $912M | $50M |
| Gross MarginGross profit ÷ Revenue | +80.2% | +61.3% | +85.5% | +23.4% |
| Operating MarginEBIT ÷ Revenue | +2.7% | +48.5% | +64.3% | +14.7% |
| Net MarginNet income ÷ Revenue | -13.0% | +36.8% | +51.0% | +24.2% |
| FCF MarginFCF ÷ Revenue | +4.5% | +56.1% | +73.6% | +17.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -2.6% | +29.7% | +16.7% | +3.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -5.3% | +10.8% | +42.4% | -36.4% |
Valuation Metrics
CLPR leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 23.7x trailing earnings, VRE trades at a 5% valuation discount to NHI's 24.9x P/E. On an enterprise value basis, CLPR's 0.6x EV/EBITDA is more attractive than VRE's 23.1x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $50M | $3.6B | $13.7B | $1.8B |
| Enterprise ValueMkt cap + debt − cash | $20M | $4.8B | $18.0B | $3.1B |
| Trailing P/EPrice ÷ TTM EPS | -6.64x | 24.85x | 23.78x | 23.71x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 22.17x | 23.40x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.02x | — |
| EV / EBITDAEnterprise value multiple | 0.55x | 17.16x | 16.72x | 23.09x |
| Price / SalesMarket cap ÷ Revenue | 0.33x | 9.61x | 11.47x | 6.17x |
| Price / BookPrice ÷ Book value/share | — | 2.29x | 2.63x | 1.52x |
| Price / FCFMarket cap ÷ FCF | 2.23x | 16.52x | 15.64x | 32.39x |
Profitability & Efficiency
OHI leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
OHI delivers a 11.9% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $6 for VRE. NHI carries lower financial leverage with a 0.76x debt-to-equity ratio, signaling a more conservative balance sheet compared to VRE's 1.07x. On the Piotroski fundamental quality scale (0–9), VRE scores 7/9 vs CLPR's 4/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | — | +9.8% | +11.9% | +5.6% |
| ROA (TTM)Return on assets | -1.6% | +5.4% | +6.1% | +2.5% |
| ROICReturn on invested capital | +0.6% | +5.6% | +6.0% | +1.3% |
| ROCEReturn on capital employed | +0.3% | +8.0% | +7.9% | +2.0% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 | 6 | 7 |
| Debt / EquityFinancial leverage | — | 0.76x | 0.78x | 1.07x |
| Net DebtTotal debt minus cash | -$31M | $1.1B | $4.2B | $1.4B |
| Cash & Equiv.Liquid assets | $31M | $20M | $27M | $14M |
| Total DebtShort + long-term debt | $0 | $1.2B | $4.3B | $1.4B |
| Interest CoverageEBIT ÷ Interest expense | — | 3.45x | 3.83x | 1.84x |
Total Returns (Dividends Reinvested)
OHI leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in OHI five years ago would be worth $16,310 today (with dividends reinvested), compared to $5,757 for CLPR. Over the past 12 months, OHI leads with a +36.9% total return vs CLPR's -14.2%. The 3-year compound annual growth rate (CAGR) favors OHI at 23.0% vs CLPR's -8.3% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -9.7% | -1.1% | +6.6% | +28.4% |
| 1-Year ReturnPast 12 months | -14.2% | +2.8% | +36.9% | +22.8% |
| 3-Year ReturnCumulative with dividends | -23.0% | +73.5% | +86.2% | +21.5% |
| 5-Year ReturnCumulative with dividends | -42.4% | +31.0% | +63.1% | +16.8% |
| 10-Year ReturnCumulative with dividends | -50.9% | +58.9% | +110.0% | -12.8% |
| CAGR (3Y)Annualised 3-year return | -8.3% | +20.2% | +23.0% | +6.7% |
Risk & Volatility
Evenly matched — OHI and VRE each lead in 1 of 2 comparable metrics.
Risk & Volatility
OHI is the less volatile stock with a -0.13 beta — it tends to amplify market swings less than CLPR's 0.95 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VRE currently trades 99.7% from its 52-week high vs CLPR's 67.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.95x | -0.08x | -0.13x | 0.22x |
| 52-Week HighHighest price in past year | $4.61 | $90.94 | $49.14 | $19.03 |
| 52-Week LowLowest price in past year | $2.83 | $68.80 | $35.09 | $13.69 |
| % of 52W HighCurrent price vs 52-week peak | +67.7% | +82.5% | +93.9% | +99.7% |
| RSI (14)Momentum oscillator 0–100 | 42.2 | 28.0 | 48.6 | 66.3 |
| Avg Volume (50D)Average daily shares traded | 70K | 332K | 1.9M | 1.2M |
Analyst Outlook
Evenly matched — CLPR and VRE each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NHI as "Hold", OHI as "Hold", VRE as "Hold". Consensus price targets imply 13.8% upside for NHI (target: $85) vs -26.2% for VRE (target: $14). For income investors, CLPR offers the higher dividend yield at 13.93% vs VRE's 1.70%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | — | $85.40 | $49.14 | $14.00 |
| # AnalystsCovering analysts | — | 18 | 28 | 12 |
| Dividend YieldAnnual dividend ÷ price | +13.9% | +4.8% | +5.4% | +1.7% |
| Dividend StreakConsecutive years of raises | 0 | 1 | 0 | 3 |
| Dividend / ShareAnnual DPS | $0.43 | $3.61 | $2.51 | $0.32 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | +0.0% |
OHI leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CLPR leads in 1 (Valuation Metrics). 2 tied.
CLPR vs NHI vs OHI vs VRE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CLPR or NHI or OHI or VRE a better buy right now?
For growth investors, Omega Healthcare Investors, Inc.
(OHI) is the stronger pick with 14. 0% revenue growth year-over-year, versus 3. 0% for Clipper Realty Inc. (CLPR). Veris Residential, Inc. (VRE) offers the better valuation at 23. 7x trailing P/E, making it the more compelling value choice. Analysts rate National Health Investors, Inc. (NHI) a "Hold" — based on 18 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CLPR or NHI or OHI or VRE?
On trailing P/E, Veris Residential, Inc.
(VRE) is the cheapest at 23. 7x versus National Health Investors, Inc. at 24. 9x. On forward P/E, National Health Investors, Inc. is actually cheaper at 22. 2x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — CLPR or NHI or OHI or VRE?
Over the past 5 years, Omega Healthcare Investors, Inc.
(OHI) delivered a total return of +63. 1%, compared to -42. 4% for Clipper Realty Inc. (CLPR). Over 10 years, the gap is even starker: OHI returned +110. 0% versus CLPR's -50. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CLPR or NHI or OHI or VRE?
By beta (market sensitivity over 5 years), Omega Healthcare Investors, Inc.
(OHI) is the lower-risk stock at -0. 13β versus Clipper Realty Inc. 's 0. 95β — meaning CLPR is approximately -842% more volatile than OHI relative to the S&P 500. On balance sheet safety, National Health Investors, Inc. (NHI) carries a lower debt/equity ratio of 76% versus 107% for Veris Residential, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CLPR or NHI or OHI or VRE?
By revenue growth (latest reported year), Omega Healthcare Investors, Inc.
(OHI) is pulling ahead at 14. 0% versus 3. 0% for Clipper Realty Inc. (CLPR). On earnings-per-share growth, the picture is similar: Veris Residential, Inc. grew EPS 420. 0% year-over-year, compared to -88. 0% for Clipper Realty Inc.. Over a 3-year CAGR, OHI leads at 10. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CLPR or NHI or OHI or VRE?
Omega Healthcare Investors, Inc.
(OHI) is the more profitable company, earning 49. 3% net margin versus -13. 0% for Clipper Realty Inc. — meaning it keeps 49. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OHI leads at 62. 6% versus 2. 7% for CLPR. At the gross margin level — before operating expenses — CLPR leads at 80. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CLPR or NHI or OHI or VRE more undervalued right now?
On forward earnings alone, National Health Investors, Inc.
(NHI) trades at 22. 2x forward P/E versus 23. 4x for Omega Healthcare Investors, Inc. — 1. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NHI: 13. 8% to $85. 40.
08Which pays a better dividend — CLPR or NHI or OHI or VRE?
All stocks in this comparison pay dividends.
Clipper Realty Inc. (CLPR) offers the highest yield at 13. 9%, versus 1. 7% for Veris Residential, Inc. (VRE).
09Is CLPR or NHI or OHI or VRE better for a retirement portfolio?
For long-horizon retirement investors, Omega Healthcare Investors, Inc.
(OHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 13), 5. 4% yield, +110. 0% 10Y return). Both have compounded well over 10 years (OHI: +110. 0%, CLPR: -50. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CLPR and NHI and OHI and VRE?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CLPR is a small-cap income-oriented stock; NHI is a small-cap income-oriented stock; OHI is a mid-cap income-oriented stock; VRE is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.